{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T08:52:41Z","timestamp":1794905561498,"version":"4.9.1"},"reference-count":47,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Med Genet"],"accepted":{"date-parts":[[2014,12,27]]},"published-print":{"date-parts":[[2015,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Fabry disease (FD), a lysosomal storage disorder caused by \u03b1-galactosidase A (\n                      <jats:italic>GLA<\/jats:italic>\n                      ) gene variants, has a heterogeneous phenotype.\n                      <jats:italic>GLA<\/jats:italic>\n                      variants can lead to classical FD, an attenuated non-classical phenotype, or no disease at all. This study investigates the value of plasma globotriaosylsphingosine (lysoGb3) to distinguish between these groups. This is of particular importance in the diagnosis of individuals with a\n                      <jats:italic>GLA<\/jats:italic>\n                      variant and an uncertain diagnosis of FD, lacking characteristic features of classical FD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Subjects with\n                      <jats:italic>GLA<\/jats:italic>\n                      variants were grouped as classical, non-classical, uncertain or no FD, using strict phenotypical, biochemical and histological criteria. Plasma lysoGb3 was assessed by LC\/MS\/MS (normal \u22640.6\u2005nmol\/L).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>154 subjects were grouped into classical (38 males (M), 66 females (F)), non-classical (13M, 14F), uncertain (5M, 9F) or no FD (6M, 3F). All subjects with a classical phenotype had elevated lysoGb3 values (M: range 45\u2013150, F: 1.5\u201341.5). LysoGb3 values in patients with a non-classical phenotype (M: 1.3\u201335.7, F: 0.5\u20132.0) were different from healthy controls (M: p&lt;0.01, F: p&lt;0.05), but females overlapped with controls. In the no-FD group, lysoGb3 was normal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>LysoGb3 is a reliable diagnostic tool to discern classical FD from subjects without FD. This study suggests that the same applies to patients with a non-classical phenotype. LysoGb3 values of female patients overlap with controls. Consequently, in uncertain cases, increased lysoGb3 values are very suggestive for FD, but normal values cannot exclude FD. Confirmation in larger cohorts and data on the specificity of small lysoGb3 increases are necessary.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jmedgenet-2014-102872","type":"journal-article","created":{"date-parts":[[2015,1,17]],"date-time":"2015-01-17T06:32:27Z","timestamp":1421476347000},"page":"262-268","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":155,"title":["Plasma globotriaosylsphingosine in relation to phenotypes of Fabry disease"],"prefix":"10.1136","volume":"52","author":[{"given":"Bouwien E","family":"Smid","sequence":"first","affiliation":[{"name":"Division Endocrinology and Metabolism, Department of Internal Medicine, Amsterdam lysosome center \u2018Sphinx\u2019, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"van der Tol","sequence":"additional","affiliation":[{"name":"Division Endocrinology and Metabolism, Department of Internal Medicine, Amsterdam lysosome center \u2018Sphinx\u2019, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke","family":"Biegstraaten","sequence":"additional","affiliation":[{"name":"Division Endocrinology and Metabolism, Department of Internal Medicine, Amsterdam lysosome center \u2018Sphinx\u2019, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabor E","family":"Linthorst","sequence":"additional","affiliation":[{"name":"Division Endocrinology and Metabolism, Department of Internal Medicine, Amsterdam lysosome center \u2018Sphinx\u2019, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla E M","family":"Hollak","sequence":"additional","affiliation":[{"name":"Division Endocrinology and Metabolism, Department of Internal Medicine, Amsterdam lysosome center \u2018Sphinx\u2019, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben J H M","family":"Poorthuis","sequence":"additional","affiliation":[{"name":"Laboratory of Genetic Metabolic Diseases, Amsterdam lysosome center \u2018Sphinx\u2019, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2015,1,16]]},"reference":[{"key":"2025101721364435000_52.4.262.1","unstructured":"The Human Genome Mutation Database. http:\/\/www.hgmd.org"},{"key":"2025101721364435000_52.4.262.2","doi-asserted-by":"publisher","DOI":"10.1086\/504601"},{"key":"2025101721364435000_52.4.262.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2012.07.011"},{"key":"2025101721364435000_52.4.262.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61266-X"},{"key":"2025101721364435000_52.4.262.5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.109.862920"},{"key":"2025101721364435000_52.4.262.6","doi-asserted-by":"publisher","DOI":"10.1002\/humu.21074"},{"key":"2025101721364435000_52.4.262.7","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00160.x"},{"key":"2025101721364435000_52.4.262.8","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2010.200188"},{"key":"2025101721364435000_52.4.262.9","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2011-300364"},{"key":"2025101721364435000_52.4.262.10","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000124671.61963.1E"},{"key":"2025101721364435000_52.4.262.11","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2010.25.4.415"},{"key":"2025101721364435000_52.4.262.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199508033330504"},{"key":"2025101721364435000_52.4.262.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.10.005"},{"key":"2025101721364435000_52.4.262.14","doi-asserted-by":"crossref","unstructured":"Smid BE , Hollak CE , Poorthuis BJ , van den Bergh Weerman MA , Florquin S , Kok WE , Lekanne Deprez RH , Timmermans J , Linthorst GE . Diagnostic dilemmas in Fabry disease: a case series study on GLA mutations of unknown clinical significance. Clin Genet 2014. doi:10.1111\/cge.12449doi:10.1111\/cge.12449","DOI":"10.1111\/cge.12449"},{"key":"2025101721364435000_52.4.262.15","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2013-101857"},{"key":"2025101721364435000_52.4.262.16","unstructured":"The Hamlet study: Fabry or not Fabry, Valorization of clinical and laboratory assessments for improved diagnosis of Fabry disease. 2012. http:\/\/www.trialregister.nl"},{"key":"2025101721364435000_52.4.262.17","unstructured":"Van der Tol L, \u00dc\u00e7eyler N, Burlina A, DeDeyn PP, Ginsberg L, Hughes DA, De Leeuw FE, Linthorst GE, Majoie CB, Manara R, Van Schaik IN, Menegatti Rafael, Hollak CE, Vedolin LM, Biegstraaten M. The value of specific brain imaging characteristics in the diagnosis of Fabry disease. 2014; submitted."},{"key":"2025101721364435000_52.4.262.18","doi-asserted-by":"crossref","unstructured":"van der Tol L , Svarstad E , Ortiz A , Tondel C , Oliveira JP , Vogt L , Waldek S , Hughes DA , Lachmann RH , Terryn W , Hollak CE , Florquin S , van den Bergh Weerman MA , Wanner C , West ML , Biegstraaten M , Linthorst GE . Chronic kidney disease and an uncertain diagnosis of Fabry disease: approach to a correct diagnosis. Mol Genet Metab 2014. doi:10.1016\/j.ymgme.2014.08.007","DOI":"10.1016\/j.ymgme.2014.08.007"},{"key":"2025101721364435000_52.4.262.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2014.09.001"},{"key":"2025101721364435000_52.4.262.20","doi-asserted-by":"publisher","DOI":"10.1007\/8904_2014_342"},{"key":"2025101721364435000_52.4.262.21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0712309105"},{"key":"2025101721364435000_52.4.262.22","doi-asserted-by":"publisher","DOI":"10.1021\/ac404000d"},{"key":"2025101721364435000_52.4.262.23","doi-asserted-by":"publisher","DOI":"10.1021\/ac303033v"},{"key":"2025101721364435000_52.4.262.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2010.05.003"},{"key":"2025101721364435000_52.4.262.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2010.03.020"},{"key":"2025101721364435000_52.4.262.26","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2012.192138"},{"key":"2025101721364435000_52.4.262.27","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jchromb.2011.11.020","article-title":"Quantification of the Fabry marker lysoGb3 in human plasma by tandem mass spectrometry","volume":"883\u2013884","author":"Kruger","year":"2012","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"2025101721364435000_52.4.262.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2012.09.026"},{"key":"2025101721364435000_52.4.262.29","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.113.000249"},{"key":"2025101721364435000_52.4.262.30","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfi191"},{"key":"2025101721364435000_52.4.262.31","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-013-2118-0"},{"key":"2025101721364435000_52.4.262.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2013.09.008"},{"key":"2025101721364435000_52.4.262.33","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-9-96"},{"key":"2025101721364435000_52.4.262.34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003632"},{"key":"2025101721364435000_52.4.262.35","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2003.09.022"},{"key":"2025101721364435000_52.4.262.36","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-012-9547-1"},{"key":"2025101721364435000_52.4.262.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2012.10.018"},{"key":"2025101721364435000_52.4.262.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2012.01.010"},{"key":"2025101721364435000_52.4.262.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2012.11.003"},{"key":"2025101721364435000_52.4.262.40","doi-asserted-by":"publisher","DOI":"10.1002\/humu.10275"},{"key":"2025101721364435000_52.4.262.41","doi-asserted-by":"publisher","DOI":"10.1016\/S1096-7192(03)00136-7"},{"key":"2025101721364435000_52.4.262.42","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"2025101721364435000_52.4.262.43","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(81)90384-3"},{"key":"2025101721364435000_52.4.262.44","first-page":"157","article-title":"Fabry's disease: enzymatic diagnosis of hemizygotes and heterozygotes. \u03b1-galactosidase activities in plasma, serum, urine, and leukocytes","volume":"81","author":"Desnick","year":"1973","journal-title":"J Lab Clin Med"},{"key":"2025101721364435000_52.4.262.45","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2006.079012"},{"key":"2025101721364435000_52.4.262.46","first-page":"905743","article-title":"A single lung transplant in a patient with Fabry disease: causality or far-fetched? A case report","volume":"2013","author":"Gaggl","year":"2013","journal-title":"Case Rep Transplant"},{"key":"2025101721364435000_52.4.262.47","first-page":"101","article-title":"Questioning the pathogenic role of the GLA p.Ala143Thr \u201cMutation\u201d in Fabry disease: implications for screening studies and ERT","volume":"8","author":"Terryn","year":"2013","journal-title":"JIMD Rep"}],"container-title":["Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jmedgenet-2014-102872","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T04:36:55Z","timestamp":1760762215000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmedgenet-2014-102872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,16]]},"references-count":47,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,3,16]]},"published-print":{"date-parts":[[2015,4]]}},"alternative-id":["10.1136\/jmedgenet-2014-102872"],"URL":"https:\/\/doi.org\/10.1136\/jmedgenet-2014-102872","relation":{},"ISSN":["0022-2593","1468-6244"],"issn-type":[{"value":"0022-2593","type":"print"},{"value":"1468-6244","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,16]]}}}